|
| Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Bullion ~ Forex ~ Sports ~ Technology ~ Health ~ Features |
| Lung Cancer ~ Lung Cancer ~ Breast Cancer ~ Heart attack ~ All Health Topics |
|
Home
/ Health News / 2008 / November 2008 / November 25, 2008 Novel approach to block prostate cancer development identified |
Women, not men, are the most dedicated players of hard-core online games
Diguang International Appoints Jerry Yu Chief Operating Officer
Sack lunches may not provide adequate nutrients to preschooler
Packing lunch for your child might not be a good idea, for a new study has found that sack lunches may not regularly provide adequate nutrients for the growth and development of young children. ANI
Health-monitoring system helps maintain older adults well-being
Many older adults want to remain active and independent for as long as possible. Now, researchers from University of Missouri suggest that installing health monitoring system can help keep check on the health of the elderly and ensure their privacy. ANI
New drug shows potential to treat angina, other cardiac problems
A compound, designed to prevent chest pains in heart patients, could act as a drug to treat angina and possibly other cardiac pathologies, according to a study on animals. ANI
Researchers from the University of Southern California (USC) have identified a novel approach that can block the development of prostate cancer.
Washington, Nov 25 : Researchers from the University of Southern California (USC) have identified a novel approach that can block the development of prostate cancer.
In the study conducted using animal models has found that inactivating a specific protein associated with cancer development inhibits prostate tumour progression.
"This research has far-reaching implications in a wide range for human cancers," said Amy Lee, Ph.D., the study's principal investigator and the associate director for basic research and holder of the Freeman Cosmetics Chair at the USC/Norris Comprehensive Cancer Center, and professor of biochemistry and molecular biology at the Keck School of Medicine of USC.
"It is a breakthrough study," she added.
Lee said that the glucose-regulated protein GRP78 has been identified as a crucial entity in the development of prostate cancer by promoting cancer cell proliferation, mediating oncogenic signalling and protecting cancer cells against cell death resulting from the stress of tumor development.
By suppressing GRP78 expression or activity, the researchers found that they could block prostate cancer activation and development resulting from the loss of PTEN, a powerful tumour suppressor gene for a number of human cancers.
"To our knowledge, this is the first demonstration that inactivation of a specific molecular chaperone from the mouse prostate epithelial cells can potently block prostate cancer development and suppress the activation of AKT, which is a protein kinase that promotes cell proliferation and survival and is a major factor in many types of cancer," she said.
"With the recent advances in identifying agents that suppress GRP78 expression, anti-GRP78 therapy may open up an entirely new approach to stop human cancer," she added.
The study appears in the Proceedings of the National Academy of Sciences.
ANI
